The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment
Open accessAbstract
This review aims to summarize the latest knowledge on factors, diagnosis, and treatment of pancreatic cancer, and aims to promote further research on this under-studied malignant tumor. At present, we urgently need to identify high-risk patients with precancerous diseases through screening approaches, so that medical professionals and the general public may better understand prevention strategies or early detection measures. Pancreatic cancer is a highly invasive malignant tumor with a fatal risk, mainly seen in men and older adults (60-85 years old). Pancreatic cancer is now increasingly observed in young patients. Because the disease has no early symptoms and can quickly invade surrounding tissues and organs, it is one of the deadliest cancers. With a view to identify the important factors for the development of pancreatic cancer, previous studies have found that smoking, alcohol, and chronic pancreatitis are considered high-risk factors. Recent studies have shown that abnormal metabolism of human microorganisms, blood type, and glucose and lipid levels are also important factors in the development of pancreatic cancer. Identifying early diagnosis options is an important way to improve detection and survival rates of pancreatic cancer. None of the many tumor markers associated with pancreatic cancer are highly specific, which also indicates further research is required to improve the early detection rate. Future directions in terms of treatment evaluating the relationship between the microbiology-free system and immunotherapy will bring a major breakthrough and is expected to bring exciting clinical applications in improving the life-cycle of pancreatic cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,816
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
(2012) · Hepatogastroenterology · doi:10.5754/hge12281 · Cited by 2,097
How colonization by microbiota in early life shapes the immune system
Gensollen, T., Iyer, S. S., Kasper, D. L., & Blumberg, R. S. (2016) · Science · doi:10.1126/science.aad9378 · Cited by 2,044
The Epidemiology of Pancreatitis and Pancreatic Cancer
Yadav, D., & Lowenfels, A. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.068 · Cited by 1,974
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,908
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Gillen, S., Schuster, T., Meyer zum Büschenfelde, C., Friess, H., & Kleeff, J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000267 · Cited by 1,552
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404 · cited 1×
“Studies have shown that the occurrence, development and prognosis of PC are closely related to the human microbiota.(31,32) Specific oral, gastrointestinal and pancreatic microbes, as well as some hepatitis viruses and bile, may have potential etiological effects in the development of PC.”
BackgroundPushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita, G., Racchumi, G., Ling, L., Pamer, E. G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4068 · Cited by 1,114
Optimizing the outcomes of pancreatic cancer surgery
Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0112-1 · Cited by 943
Goonetilleke, K. S., & Siriwardena, A. K. (2007) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2006.10.004 · Cited by 877
Loehrer, P. J., Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., Flynn, P., Ramanathan, R. K., Crane, C. H., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8904 · Cited by 830
Epidemiology of pancreatic cancer: an overview
Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.177 · Cited by 740
Fan, X., Alekseyenko, A. V., Wu, J., Peters, B. A., Jacobs, E. J., Gapstur, S. M., Purdue, M. P., Abnet, C. C., Stolzenberg-Solomon, R., Miller, G., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312580 · Cited by 702
Petersen, G. M., Amundadottir, L., Fuchs, C. S., Kraft, P., Stolzenberg-Solomon, R. Z., Jacobs, K. B., Arslan, A. A., Bueno-de-Mesquita, H. B., Gallinger, S., Gross, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.522 · Cited by 596
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Patel, S. A., & Minn, A. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.007 · Cited by 573
Tobacco and the risk of pancreatic cancer: a review and meta-analysis
Iodice, S., Gandini, S., Maisonneuve, P., & Lowenfels, A. B. (2008) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-007-0266-2 · Cited by 542
Benci, J. L., Johnson, L. R., Choa, R., Xu, Y., Qiu, J., Zhou, Z., Xu, B., Ye, D., Nathanson, K. L., June, C. H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.019 · Cited by 541
Hackert, T., Sachsenmaier, M., Hinz, U., Schneider, L., Michalski, C. W., Springfeld, C., Strobel, O., Jäger, D., Ulrich, A., & Büchler, M. W. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001850 · Cited by 529
Human Gut Microbiota and Gastrointestinal Cancer
Meng, C., Bai, C., Brown, T. D., Hood, L. E., & Tian, Q. (2018) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.06.002 · Cited by 467
Cancer and the gut microbiota: An unexpected link
Zitvogel, L., Galluzzi, L., Viaud, S., Vétizou, M., Daillère, R., Merad, M., & Kroemer, G. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010473 · Cited by 465 · cited 1×
“After continuous intake of antibiotics, researchers induced microbial disorders in mice and found that the incidence of various extraintestinal tumors including PC was found to be significantly elevated.(52) A growing body of evidence suggests that microbial dysbiosis is associated with susceptibility, occurrence and…”
BackgroundHigh-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
Schulz, M. D., Atay, Ç., Heringer, J., Romrig, F. K., Schwitalla, S., Aydin, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., et al. (2014) · Nature · doi:10.1038/nature13398 · Cited by 453
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Schultz, N. A., Dehlendorff, C., Jensen, B. V., Bjerregaard, J. K., Nielsen, K. R., Bojesen, S. E., Calatayud, D., Nielsen, S. E., Yilmaz, M., Holländer, N. H., et al. (2014) · JAMA · doi:10.1001/jama.2013.284664 · Cited by 450
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy162 · Cited by 431 · cited 1×
“Immune checkpoint blockade (ICB) therapy is now approved for various types of cancer, such as melanoma, lung cancer, renal cell carcinoma, and head and neck squamous cell carcinoma.(129) However, PC is considered to be a less immunogenic cancer.”
BackgroundRole of lipoteichoic acid in infection and inflammation
Ginsburg, I. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00226-8 · Cited by 425
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 402
Daley, D., Mani, V. R., Mohan, N., Akkad, N., Ochi, A., Heindel, D. W., Lee, K. B., Zambirinis, C. P., Pandian, G. S. B., Savadkar, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4314 · Cited by 381
Middleton, G., Silcocks, P., Cox, T., Valle, J., Wadsley, J., Propper, D., Coxon, F., Ross, P., Madhusudan, S., Roques, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70236-0 · Cited by 378
Hold, G. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1192 · Cited by 365
Ahn, J., Segers, S., & Hayes, R. B. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs112 · Cited by 342
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Becker, A. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11182 · Cited by 327
Immune-microbiota interactions in health and disease
Palm, N. W., de Zoete, M. R., & Flavell, R. A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.014 · Cited by 315
Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer
Liu, J., Gao, J., Du, Y., Li, Z., Ren, Y., Gu, J., Wang, X., Gong, Y., Wang, W., & Kong, X. (2012) · International Journal of Cancer · doi:10.1002/ijc.26422 · Cited by 309
Ciccone, M., Bux, F., Cortese, Aquilino, Pomo, Mola, Musilli, Panfilo, Rollo, Caldarola, et al. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s9252 · Cited by 305
Bosetti, C., Rosato, V., Li, D., Silverman, D., Petersen, G. M., Bracci, P. M., Neale, R. E., Muscat, J., Anderson, K., Gallinger, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu276 · Cited by 283
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
Midha, S., Chawla, S., & Garg, P. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.022 · Cited by 281
Chemotherapy for pancreatic cancer
Springfeld, C., Jäger, D., Büchler, M. W., Strobel, O., Hackert, T., Palmer, D. H., & Neoptolemos, J. P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.02.025 · Cited by 281
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
Cicenas, J., Kvederaviciute, K., Meskinyte, I., Meskinyte-Kausiliene, E., Skeberdyte, A., & Cicenas, J. (2017) · Cancers · doi:10.3390/cancers9050042 · Cited by 272
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Klein, A. P., Wolpin, B. M., Risch, H. A., Stolzenberg-Solomon, R. Z., Mocci, E., Zhang, M., Canzian, F., Childs, E. J., Hoskins, J. W., Jermusyk, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02942-5 · Cited by 268
Update on Familial Pancreatic Cancer
Hruban, R. H., Canto, M. I., Goggins, M., Schulick, R., & Klein, A. P. (2010) · Advances in Surgery · doi:10.1016/j.yasu.2010.05.011 · Cited by 268
The microbiota and microbiome in pancreatic cancer: more influential than expected
Wei, M.-Y., Shi, S., Liang, C., Meng, Q.-C., Hua, J., Zhang, Y.-Y., Liu, J., Zhang, B., Xu, J., & Yu, X.-J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1008-0 · Cited by 268
Pancreatic Cancer: Pathogenesis and Diagnosis
Goral, V. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.14.5619 · Cited by 259
An obligatory role for neurotensin in high-fat-diet-induced obesity
Li, J., Song, J., Zaytseva, Y. Y., Liu, Y., Rychahou, P., Jiang, K., Starr, M. E., Kim, J. T., Harris, J. W., Yiannikouris, F. B., et al. (2016) · Nature · doi:10.1038/nature17662 · Cited by 259
Brown, D. G., Rao, S., Weir, T. L., O’Malia, J., Bazan, M., Brown, R. J., & Ryan, E. P. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0151-y · Cited by 254
Wolpin, B. M., Kraft, P., Gross, M., Helzlsouer, K., Bueno-de-Mesquita, H. B., Steplowski, E., Stolzenberg-Solomon, R. Z., Arslan, A. A., Jacobs, E. J., LaCroix, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2993 · Cited by 252
Hayashi, C., Gudino, C. V., Gibson III, F. C., & Genco, C. A. (2010) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2010.00582.x · Cited by 244
Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis.
Zhang, Y., Yang, J. J., Li, H., Wu, Y., Zhang, H., & Chen, W. (2015) · PubMed · Cited by 208
Alcohol Intake and Pancreatic Cancer Risk: A Pooled Analysis of Fourteen Cohort Studies
Genkinger, J. M., Spiegelman, D., Anderson, K. E., Bergkvist, L., Bernstein, L., van den Brandt, P. A., English, D. R., Freudenheim, J. L., Fuchs, C. S., Giles, G. G., et al. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0880 · Cited by 201
Samokhvalov, A. V., Rehm, J., & Roerecke, M. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.023 · Cited by 200
Fattahi, R., Balci, N. C., Perman, W. H., Hsueh, E. C., Alkaade, S., Havlioglu, N., & Burton, F. R. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21651 · Cited by 195
Wu, C., Miao, X., Huang, L., Che, X., Jiang, G., Yu, D., Yang, X., Cao, G., Hu, Z., Zhou, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1020 · Cited by 195
Wang, Y.-T., Gou, Y.-W., Jin, W.-W., Xiao, M., & Fang, H.-Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2241-1 · Cited by 179
Fritz, S., Hackert, T., Hartwig, W., Rossmanith, F., Strobel, O., Schneider, L., Will-Schweiger, K., Kommerell, M., Büchler, M. W., & Werner, J. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.08.019 · Cited by 167
Demographics, Epidemiology, and Inheritance of Pancreatic Ductal Adenocarcinoma
Yeo, T. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.002 · Cited by 164
Risch, H. A., Yu, H., Lu, L., & Kidd, M. S. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq007 · Cited by 163
Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota
Mishra, A. K., Dubey, V., & Ghosh, A. R. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.008 · Cited by 161
Early detection and prevention of pancreatic cancer: Is it really possible today?
Chiaro, M. D., Segersvärd, R., Lohr, M., & Verbeke, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12118 · Cited by 160
Pathology and Molecular Genetics of Pancreatic Neoplasms
Wood, L. D., & Hruban, R. H. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827459b6 · Cited by 160
Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd‐Williams, H., Yeo, S. T., Edwards, R. T., Johnson, C., Hilal, M. A., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22070 · Cited by 152
Genome-Wide Association Study of Pancreatic Cancer in Japanese Population
Low, S., Kuchiba, A., Zembutsu, H., Saito, A., Takahashi, A., Kubo, M., Daigo, Y., Kamatani, N., Chiku, S., Totsuka, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011824 · Cited by 148
Kimura, H., Yamamoto, H., Harada, T., Fumoto, K., Osugi, Y., Sada, R., Maehara, N., Hikita, H., Mori, S., Eguchi, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2124 · Cited by 145
Chemotherapy and radiotherapy for advanced pancreatic cancer
Chin, V. T., Nagrial, A. M., Sjoquist, K. M., O'Connor, C. A., Chantrill, L. A., Biankin, A. V., Scholten, R. J. P. M., & Yip, D. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011044.pub2 · Cited by 141
Hermann, C., Spreitzer, I., Schröder, N. W. J., Morath, S., Lehner, M. D., Fischer, W., Schütt, C., Schumann, R. R., & Härtung, T. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<541::aid-immu541>3.0.co;2-p · Cited by 132
Nwizu, N. N., Marshall, J. R., Moysich, K. B., Genco, R. J., Hovey, K. M., Mai, X., LaMonte, M. J., Freudenheim, J. L., & Wactawski‐Wende, J. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0212 · Cited by 130
Microbiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 129
Shin, S. H., Kim, S. C., Song, K. B., Hwang, D. W., Lee, J. H., Lee, D., Lee, J. W., Jun, E., Park, K., & Lee, Y. J. (2014) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.10.014 · Cited by 128
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Feng, L., Qi, Q., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Journal of International Medical Research · doi:10.1177/0300060518800588 · Cited by 125
ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-Analysis
Risch, H. A., Lu, L., Wang, J., Zhang, W., Ni, Q., Gao, Y.-T., & Yu, H. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws458 · Cited by 122
Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
Şahin, İ. H., Askan, G., Hu, Z., & O'Reilly, E. M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx503 · Cited by 115
Heikkilä, P., But, A., Sorsa, T. A., & Haukka, J. K. (2018) · International Journal of Cancer · doi:10.1002/ijc.31254 · Cited by 114
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1
Nimmakayala, R. K., Seshacharyulu, P., Lakshmanan, I., Rachagani, S., Chugh, S., Karmakar, S., Rauth, S., Vengoji, R., Atri, P., Talmon, G. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.041 · Cited by 106
Maekawa, T., Fukaya, R., Takamatsu, S., Itoyama, S., Fukuoka, T., Yamada, M., Hata, T., Nagaoka, S., Kawamoto, K., Eguchi, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.169 · Cited by 106
Indicative findings of pancreatic cancer in prediagnostic CT
Ahn, S. S., Kim, M.-J., Choi, J.-Y., Hong, H.-S., Chung, Y. E., & Lim, J. S. (2009) · European Radiology · doi:10.1007/s00330-009-1422-6 · Cited by 105
Takaori, K., Bassi, C., Biankin, A. V., Brunner, T. B., Cataldo, I., Campbell, F., Cunningham, D., Falconi, M., Frampton, A. E., Furuse, J., et al. (2015) · Pancreatology · doi:10.1016/j.pan.2015.10.013 · Cited by 105
Periodontal Disease and Breast Cancer: Prospective Cohort Study of Postmenopausal Women
Freudenheim, J. L., Genco, R. J., LaMonte, M. J., Millen, A. E., Hovey, K. M., Mai, X., Nwizu, N. N., Andrews, C., & Wactawski‐Wende, J. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0750 · Cited by 100
Molina‐Montes, E., van Hoogstraten, L. M. C., Gómez-Rubio, P., Löhr, M. J., Sharp, L., Molero, X., Márquez, M., Michalski, C. W., Farré, A., Perea, J., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1027 · Cited by 98
Ge, L., Pan, B., Song, F., Ma, J., Zeraatkar, D., Zhou, J., & Tian, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018175 · Cited by 96
Association between Helicobacter pylori Infection and Pancreatic Cancer Development: A Meta-Analysis
Xiao, M., Wang, Y., & Gao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075559 · Cited by 95
Landi, S. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.12.001 · Cited by 95
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 92
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling
Riquelme, E. M., Maitra, A., & McAllister, F. M. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0123 · Cited by 92
Flagellin: key target of mucosal innate immunity
Vijay–Kumar, M., & Gewirtz, A. T. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.9 · Cited by 87
Huang, B. Z., Pandol, S. J., Jeon, C. Y., Chari, S. T., Sugar, C. A., Chao, C. R., Zhang, Z.-F., Wu, B. U., & Setiawan, V. W. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.043 · Cited by 87
Microbiome and pancreatic cancer: A comprehensive topic review of literature
Ertz-Archambault, N. M., Keim, P., & Hoff, D. D. V. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i10.1899 · Cited by 86
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
He, J. P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2255 · Cited by 83
Mikata, R., Ishihara, T., Tada, M., Tawada, K., Saito, M., Kurosawa, J., Sugiyama, H., Sakai, Y., Tsuyuguchi, T., Miyazaki, M., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0684-y · Cited by 82
Seufferlein, T. T. W., Hammel, P. R., Delpéro, J., Macarulla, T. M., Pfeiffer, P., Prager, G. W., Reni, M., Falconi, M., Philip, P. A., & Cutsem, E. V. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.05.007 · Cited by 80
Exploiting inflammation for therapeutic gain in pancreatic cancer
Steele, C. W., Jamieson, N. B., Evans, T. R. J., McKay, C. J., Sansom, O. J., Morton, J. P., & Carter, C. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.24 · Cited by 79
Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis
Schulte, A., Pandeya, N., Fawcett, J., Fritschi, L., Risch, H. A., Webb, P. M., Whiteman, D. C., & Neale, R. Ε. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0595-3 · Cited by 76
Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma
Risch, H. A., Lu, L., Kidd, M. S., Wang, J., Zhang, W., Ni, Q., Gao, Y.-T., & Yu, H. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0447 · Cited by 74
A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer
Lindkvist, B., Johansen, D., Borgström, A., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-321 · Cited by 71
Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer
Daamen, L. A., Groot, V. P., Heerkens, H. D., Intven, M., van Santvoort, H. C., & Molenaar, I. Q. (2018) · HPB · doi:10.1016/j.hpb.2017.11.009 · Cited by 67
Carino, A., Graziosi, L., D’Amore, C., Cipriani, S., Marchianò, S., Marino, E., Zampella, A., Rende, M., Mosci, P., Distrutti, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10477 · Cited by 65
Metabolism and epigenetics of pancreatic cancer stem cells
Lanfranca, M. P., Thompson, J. K., Bednar, F., Halbrook, C. J., Lyssiotis, C. A., Lévi, B., & Frankel, T. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.008 · Cited by 59
History of Peptic Ulcer Disease and Pancreatic Cancer Risk in Men
Bao, Y., Spiegelman, D. L., Li, R., Giovannucci, E. L., Fuchs, C. S., & Michaud, D. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.059 · Cited by 57
Mai, X., LaMonte, M. J., Hovey, K. M. O., Nwizu, N. N., Freudenheim, J. L., Tezal, M., Scannapieco, F. A., Hyland, A. J., Andrews, C., Genco, R. J., et al. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0405-3 · Cited by 55
Swidnicka-Siergiejko, A. K., Gomez-Chou, S. B., Cruz‐Monserrate, Z., Deng, D., Liu, Y., Huang, H., Ji, B., Azizian, N. G., Daniluk, J., Lu, W., et al. (2016) · Oncogene · doi:10.1038/onc.2016.461 · Cited by 55
Oral Health and the Oral Microbiome in Pancreatic Cancer: An Overview of Epidemiological Studies
Bracci, P. M. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000287 · Cited by 55
Djurić, Z. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.017 · Cited by 53
Chen, F., Roberts, N. J., & Klein, A. P. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.12.04 · Cited by 52
Wang, Y., Zhang, F.-C., & Wang, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4449 · Cited by 46
Do smoking and alcohol behaviours influence GI cancer survival?
McMenamin, Ú. C., McCain, S., & Kunzmann, A. T. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.015 · Cited by 43
Microbiome promotes pancreatic cancer
Dickson, I. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0013-x · Cited by 43
Effects of Helicobacter pylori infection on human pancreatic cancer cell line.
Takayama, S., Takahashi, H., Matsuo, Y., et al. (2007) · PubMed · Cited by 42
Pancreatic cancer screening: state of the art
Gemmel, C., Eickhoff, A., Helmstädter, L., & Riemann, J. F. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.3.1.89 · Cited by 40
B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
Shen, L., Qian, Y., Wu, W., Weng, T.-H., Wang, F. X. C., Hong, B., Wu, Z., Wang, Q., Sang, Y., Zhang, H., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.05.023 · Cited by 40
Seropositivity to Helicobacter pylori and Risk of Pancreatic Cancer
Yu, G., Murphy, G. A., Michel, A., Weinstein, S. J., Männistö, S., Albanes, D., Pawlita, M., & Stolzenberg‐Solomon, R. Z. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0680 · Cited by 38
Oh, J. H., Kim, M. J., Choi, S. J., Ban, Y. H., Lee, H. K., Shin, E., Lee, K.-M., & Ha, S. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0403 · Cited by 37
Li, X., Xu, H., & Gao, P. (2018) · Medical Science Monitor · doi:10.12659/msm.913769 · Cited by 33
Beyond Digestion: The Pancreas Shapes Intestinal Microbiota and Immunity
Tilg, H., & Adolph, T. E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.018 · Cited by 30
Li, H., Hu, Z., Chen, J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2154-z · Cited by 27
Middleton, G., Greenhalf, W., Costello, E., Shaw, V. E., Cox, T. F., Ghaneh, P., Palmer, D. H., & Neoptolemos, J. P. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.468 · Cited by 24
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
Lee, B., & Gibbs, P. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9020020 · Cited by 24
Hufnagl, C., Leisch, M., Weiß, L., Melchardt, T., Moik, M., Asslaber, D., Geisberger, R., Steininger, P. A., Meißnitzer, T., Neureiter, D., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.11192 · Cited by 17
Editorial on "Cancer and the microbiota" published in Science.
Hamm, A. K., & Weir, T. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.07.16 · Cited by 16
Menstrual and Reproductive Factors and Risk of Pancreatic Cancer in Women
Masoudi, S., Sanat, Z. M., Saleh, A. M., Nozari, N., Shishavan, N. G., & Pourshams, A. (2017) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2017.65 · Cited by 16
Downes, D. P., Daurio, N. A., McLaren, D. G., Carrington, P. E., Previs, S. F., & Williams, K. B. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00219 · Cited by 16
Gu, J., Wang, D., Huang, Y. F., Lü, Y., & Peng, C. (2014) · PubMed Central · Cited by 13
The Effect of Neoadjuvant Chemoradiation on Pancreatic Cancer-Associated Diabetes Mellitus
Gardner, T. B., Hessami, N., Smith, K. D., Ripple, G. H., Barth, R. J., Klibansky, D. A., Colacchio, T. A., Zaki, B. I., Tsapakos, M. J., Suriawinata, A. A., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000162 · Cited by 12
Rustgi, S. D., Amin, S., Kim, M. K., Nagula, S., Kumta, N. A., DiMaio, C. J., Boffetta, P., & Lucas, A. L. (2019) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v11.i2.133 · Cited by 12
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma
Zhen, D. B., Coveler, A. L., Zanon, S. M., Reni, M., & Chiorean, E. G. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.05.004 · Cited by 11
Metadata
- Authors
- Zhao, Z., & Liu, W.
- Venue
- Technology in Cancer Research & Treatment
- Publisher
- SAGE Publications
- Published
- 2020-01-01
- Volume
- 19
- Pages
- 1533033820962117-1533033820962117
- ISSN
- 1533-0338 (ISSN-L)
- 1533-0346
- OpenAlex
- W3116521081
- Cited by
- 348
- References
- 134
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.